CU Cancer Center member Kian Behbahkt, MD, MBA, is leading a pioneering effort to detect ovarian cancer in its earliest stages. Through a partnership with women-founded AOA Diagnostics, his team is accelerating research on a first-of-its-kind blood test that could save countless lives.